MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.

Husain SS, Szabo IL, Pai R, Soreghan B, Jones MK, Tarnawski AS

Open source

DOI
10.1016/s0024-3205(01)01411-4
Published
2001 Nov 9
Container
Life sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0024-3205-01-01411-4,
  title = {MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.},
  author = {Husain SS and Szabo IL and Pai R and Soreghan B and Jones MK and Tarnawski AS},
  year = {2001},
  journal = {Life sciences},
  doi = {10.1016/s0024-3205(01)01411-4},
  url = {https://doi.org/10.1016/s0024-3205(01)01411-4}
}

RIS

TY  - JOUR
TI  - MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.
AU  - Husain SS
AU  - Szabo IL
AU  - Pai R
AU  - Soreghan B
AU  - Jones MK
AU  - Tarnawski AS
PY  - 2001
JO  - Life sciences
DO  - 10.1016/s0024-3205(01)01411-4
UR  - https://doi.org/10.1016/s0024-3205(01)01411-4
ER  - 

APA

SS, H., IL, S., R, P., B, S., MK, J., & AS, T. (2001). MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.. Life sciences. https://doi.org/10.1016/s0024-3205(01)01411-4

Source records